Tafirol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tafirol

Quick Facts: Tafirol at a Glance

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Oral (Tablets, Suspensions)
Pharmacological Class Aniline Analgesic and Antipyretic
General Purpose Symptomatic relief of pain and fever
Origin Synthetic Compound

What is Tafirol, and What is its Active Ingredient?

Tafirol is a well-established synthetic medicine classified primarily as a simple analgesic (pain reliever) and antipyretic (fever reducer). The sole active component responsible for its therapeutic action is Paracetamol, also known as the International Nonproprietary Name (INN) Acetaminophen.

This medication is a popular brand, often recognized in markets for its specialized pediatric suspensions and effervescent tablets, offering patients alternative oral dose forms. Its widespread use and effectiveness have led to the classification of Paracetamol as an essential medicine required in a basic health system.


What Class of Medication Does Tafirol Belong to?

Tafirol is scientifically categorized as an aniline analgesic and is pharmacologically distinct from the class of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Its general therapeutic purpose is squarely focused on managing and alleviating common symptoms, such as the pain associated with a headache or reducing an elevated body temperature.

The medication is clinically recognized because its primary site of action is centered in the central nervous system, which results in minimal anti-inflammatory activity compared to NSAIDs. The primary function of Paracetamol is the reduction of pain intensity and the lowering of fever, solidifying its foundational role in symptomatic relief.

Regulatory References

  1. WHO Essential Medicines List
  2. Acetaminophen: MedlinePlus Drug Information

What side effects are possible with Tafirol?

Possible Side Effects and Safety Information for Tafirol

Tafirol, which contains the active ingredient paracetamol (acetaminophen), is generally well-tolerated at recommended doses, but its safety profile is dominated by the risk of severe hepatotoxicity (liver damage), particularly in cases of overdose. This is the most critical and life-threatening adverse reaction, potentially leading to liver failure and death.

Key Adverse Reactions and Safety Concerns

System-Organ Class Serious/Clinically Significant Adverse Reactions
Hepatobiliary Disorders Acute liver failure/damage; dose-related toxicity
Skin Disorders Rare, severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
Immune System Disorders Rare hypersensitivity/allergic reactions, including anaphylaxis
Metabolic/Nutritional Risk of metabolic acidosis, particularly in patients with severe infection

Safety Limitations and High-Level Notes

The risk of serious liver injury is sharply increased when the maximum recommended daily dose is exceeded or if other paracetamol-containing products are taken simultaneously. Regulatory documentation strictly mandates the inclusion of warnings about the potential for liver damage, even if an overdose is initially asymptomatic.

Caution is advised for specific populations, including those with pre-existing liver disease or chronic alcoholism, as these factors elevate the risk of hepatotoxicity. Use in patients with severe renal impairment or severe active liver disease is often contraindicated or requires reduced dosages and careful monitoring. Any sign of a skin rash or allergic reaction necessitates immediate discontinuation of the medicine. The maximum total daily dose from all sources must be strictly limited to prevent irreversible damage.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory guidance for Tafirol (Paracetamol/Acetaminophen) overdose emphasizes the immediate need for medical intervention, even when initial symptoms are absent.

Documented Overdose Profile

Element Official Regulatory Information
Initial Manifestations Nausea, vomiting, pallor, and abdominal pain are common early symptoms (within the first 24 hours), but many patients may be asymptomatic initially.
Serious Outcomes The primary risk is acute liver failure, which can be delayed by 24 to 72 hours, potentially leading to encephalopathy, coma, and death. Acute kidney injury is also a documented outcome.

Emergency Action Required

Immediate medical attention or contact with a Poison Control Center is mandatory in all cases of suspected overdose, regardless of symptoms.

This urgent action is crucial because the standard antidote, N-acetylcysteine (NAC), must be administered as soon as possible for maximum effectiveness in preventing irreversible liver damage. Management requires mandatory hospital monitoring of blood levels (e.g., plasma paracetamol concentration) and hepatic function tests. Specific populations, including patients with existing liver impairment, chronic malnutrition, or those taking certain enzyme-inducing drugs, are noted in regulatory documents as being at increased risk for toxicity.

Therapeutic Uses of Tafirol

What Tafirol Treats: Main Uses and Benefits

Tafirol (Paracetamol/Acetaminophen) is relevant for symptomatic support across key domains where acute discomfort and elevated temperature interfere with daily stability. It is used for temporary assistance and supports the patient during difficult episodes by easing distress. Its main therapeutic function is as an analgesic and antipyretic.

The medication is commonly used to help with the burden of mild to moderate pain that occurs suddenly or episodically, including tension headaches, minor muscle aches, toothaches, and the aches associated with seasonal illnesses. Its role as an antipyretic is relevant for easing elevated body temperature (fever) during conditions like the cold or flu.

Quick Fact: Relief for Dual Symptoms

Symptom Type Context Benefit
Pain (Aches) Episodic discomfort Contributes to improved comfort
Fever (High Temp) Systemic imbalance Supports symptomatic stability

Addressing both pain and fever simultaneously, Tafirol provides support that helps ease the overall symptom burden. It is relevant in clinical settings that involve acute or unstable symptom patterns, helping patients cope more steadily when symptoms are more noticeable.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Tafirol (which contains paracetamol, also known as acetaminophen) is generally safe when used as directed. It is primarily used to relieve mild to moderate pain and reduce fever, and is safe for use across a wide age range.

Who Can Use Tafirol?

Group General Guideline
Adults Safe, following standard dosage guidelines.
Children Safe for use, with dosage based on weight and age. Specific pediatric formulations are available.
Pregnant/Breastfeeding Generally considered safe for short-term use, but consult a healthcare professional.

Who Should NOT Use Tafirol or Use With Caution?

This medication is contraindicated for individuals with a known hypersensitivity or allergy to paracetamol or any other ingredients in the formulation. Caution is necessary for people with certain pre-existing conditions, as the drug is metabolized in the liver.

  • Severe Liver Disease: Individuals with severe active liver disease should generally avoid Tafirol. Chronic, heavy alcohol consumption can also increase the risk of liver damage.
  • Severe Kidney Impairment: Dosage adjustments may be necessary for those with severe renal impairment.
  • G6PD Deficiency: Use with caution, as it may pose a risk for hemolytic anemia in these patients.

Always consult a healthcare provider before starting Tafirol, especially if you have chronic health issues.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Category Official Regulatory Documentation Summary
Medicinal product categories with documented interactions Oral Anticoagulants (Coumarins), Enzyme Inducers, Antiemetics, Anti-tuberculosis agents, Bile-acid sequestrants
Specific interacting medicines (if explicitly listed) Warfarin, Probenecid, Phenytoin, Carbamazepine, Metoclopramide, Domperidone, Cholestyramine, Flucloxacillin, other Paracetamol-containing products
Mechanistic basis of interactions (only if stated in label) Inhibition of Glucuronidation/Clearance (Probenecid), Induction of Liver Enzymes (Phenytoin, Carbamazepine) leading to increased toxic metabolite formation, Altered Gastric Emptying/Absorption Rate (Metoclopramide, Domperidone)

Interaction Classifications (High-Level)

Classification Official Regulatory Documentation Summary
Interaction severity classification Contraindicated Combination (Other Paracetamol Products), Clinically Significant (Warfarin, Enzyme Inducers)
Timing-based interaction rules Cholestyramine significantly reduces absorption; Paracetamol is required to be taken at least one hour before Cholestyramine.
Population-specific interaction notes Individuals with Risk Factors for Glutathione Depletion (e.g., chronic alcoholism) or Hepatic Impairment are at a documented increased risk for interaction-related toxicity.

The regulatory profile strictly prohibits co-administration with other Paracetamol-containing products to mitigate the risk of overdose and subsequent liver damage. Prolonged, regular use of Tafirol enhances the anticoagulant effect of Warfarin and other coumarins, which increases the documented risk of bleeding. Furthermore, the official label specifies that three or more alcoholic drinks per day significantly increase the risk of severe liver damage during use. Pharmacokinetic interactions include agents that speed up absorption, such as Metoclopramide, and liver enzyme inducers that increase hepatotoxic potential.

Mechanism of Action

The active ingredient in Tafirol, Paracetamol (Acetaminophen), acts primarily within the Central Nervous System (CNS) by engaging two distinct but complementary mechanistic domains, resulting in specific modulatory actions within the CNS.

Central Prostaglandin Modulation

This core domain involves the selective inhibition of certain Cyclooxygenase (COX) enzymes within the brain and spinal cord, which are responsible for creating the key signaling molecule Prostaglandin E2 ( PGE2). By reducing PGE2 concentration, the mechanism simultaneously reduces the chemical sensitization of pain neurons and resets the elevated set-point of the hypothalamic thermostat that regulates body temperature. This action leads directly to the alteration of nociceptive signaling and the initiation of systemic heat-dissipation processes (antipyresis).

Augmentation of Descending Pain Inhibition

An important pathway involves an active metabolite of the drug, AM404, which modulates descending inhibitory nociceptive pathways. This metabolite enhances signaling in the endocannabinoid pathway and activates serotonergic pathways descending from the brain into the spinal cord. By boosting these native inhibitory signals, the mechanism contributes to the modification of central nociceptive signaling by enhancing the activity of inhibitory neural circuits.

Dosage and Administration Information

Administration Principles and Dosage Regimens

Tafirol's usage is governed by administration principles detailed in official documents. The active ingredient, Paracetamol (Acetaminophen), is approved for administration via the oral route, as well as intravenous (IV) infusion and rectal suppository.

The standard single oral dose for adults is 500 mg to 1000 mg (1 g), which may be repeated every four to six hours as required, provided a minimum dosing interval of four hours is maintained. Critically, the maximum total daily dose from all sources (oral, IV, rectal) combined must not exceed 4000 mg (4 g) over a 24-hour period.

Administration requirements vary by formulation. Oral suspensions must be shaken prior to measurement, and the IV solution must be administered as a slow 15-minute infusion. The oral form can be taken with or without food.

Specific dosing adjustments are officially mandated for certain populations. Patients with severe renal impairment (creatinine clearance le 30 mL/min) are instructed to prolong the minimum dosing interval to 6 or 8 hours. Furthermore, the maximum daily dose is typically reduced to 3000 mg (3 g) for adults with low body weight or those with hepatic risk factors. These constraints ensure the medication is used strictly according to label-based requirements.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tafirol

The research evidence available for Tafirol (Paracetamol/Acetaminophen) describes the studies conducted related to common symptoms like pain and fever. The studies exploring this medicine examined patterns in symptom changes over time and what was observed in different patient groups. Research in this area is mostly derived from Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that gather results from many individual trials.


Evidence for Symptomatic Relief of Fever

Research has extensively examined studies related to a systemic or functional imbalance like fever. Studies monitored the degree of body temperature change and the time required for temperature alteration in the body during periods of increased symptom activity. These short-term RCTs were applied in studies examining patient-reported experiences related to fever across different age groups.

The findings describe patterns observed in the studies which included a measured change in body temperature when compared to the starting measurement. This research describes short-term changes, particularly within the first few hours after the medicine was observed in both adults and children with fever. Evidence describes these outcomes as episodic or acute changes and contributes to the broader evidence landscape for antipyretics.


Evidence for Acute Mild to Moderate Pain

The research exploring short-term symptom changes associated with pain is extensive. RCTs and meta-analyses were used in research contexts involving fluctuating or unstable symptoms related to acute physical discomfort, such as tension headaches and post-dental pain. Studies explored outcomes related to physical discomfort, including the measurement of changes in pain intensity scores and the need for additional pain medication over short time intervals.

Studies report how symptoms evolved in the observed populations and included measured differences in patient-reported outcomes describing perceived discomfort when compared to placebo in specific acute pain models. Long-term effects are not fully established for continuous use in chronic conditions, and follow-up durations were limited.


Evidence in Other Pain Contexts

For conditions like osteoarthritis (hip and knee), Tafirol was studied in conditions characterized by functional limitations. The findings describe patterns observed in the studies that were associated with small, measured changes in pain intensity and function compared to placebo. Conversely, for acute low back pain (LBP), studies reported that the measured outcomes for pain and disability status were similar to the patterns observed in the groups receiving placebo (a control). This suggests that the results apply only to the specific acute pain populations studied, and comparative evidence is lacking for chronic LBP.

Key Studies & References

  1. WHO Model List of Essential Medicines - Paracetamol
  2. Acetaminophen (Oral Route): Drug Information - NIH MedlinePlus
  3. Pain management for adults undergoing surgery (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Tafirol (FAQ)


Q: Is it normal to feel nauseous after taking Tafirol?

Regulatory documents indicate that nausea and vomiting are adverse reactions that may be reported, even if they are not common. These symptoms should be noted, as they can also be potential signs related to liver injury, particularly in cases where the maximum daily dose is exceeded. Most frequently reported side effects are generally rare and mild.


Q: Are there any known long-term effects of taking Tafirol regularly?

Regulatory warnings indicate that use of the active ingredient for pain or fever should not exceed the limits stated on the product label without consulting a healthcare professional. Official information warns that chronic, high-dose use of the active ingredient is associated with an increased risk of liver and kidney issues, which is why long-term use requires medical oversight.


Q: Does Tafirol have a known withdrawal effect?

Tafirol, which contains only acetaminophen, is not reported as habit-forming and does not typically cause physical dependence or withdrawal symptoms when used according to the label. Withdrawal effects are generally associated with pain relief medications that contain opioid components.


Q: Can Tafirol be taken on an empty stomach?

According to the official product information, the oral form of Tafirol can be taken with or without food. Taking the medication with food may slightly delay the absorption but does not affect the overall therapeutic effectiveness.


Q: Are there any clinical trials or studies supporting the use of Tafirol?

Yes, regulatory documents include a Clinical Data section that references studies, primarily Randomized Controlled Trials and comprehensive Systematic Reviews. This research forms the evidence base supporting the medication's use for the symptomatic relief of pain and fever.


Q: What is the difference between Tafirol and its generic version?

The generic version contains the identical active ingredient (Paracetamol/Acetaminophen) in the same strength and dosage form as the brand name Tafirol. Generic products are required to meet regulatory standards for quality, strength, and bioequivalence to ensure they work in the same way as the brand name product.


Q: Why do some people experience headaches when taking Tafirol?

While Tafirol is commonly used to treat headaches, official regulatory documents detailing adverse reactions indicate that headaches may rarely occur as a reported side effect in some individuals. Concerns about new or worsening headaches during use can be discussed with a healthcare professional.


Q: Does Tafirol interact with herbal supplements like St. John's Wort?

Official interaction information highlights potential issues with agents known as Enzyme Inducers, which includes some herbal supplements like St. John's Wort. These agents can affect how the drug is processed in the liver, which could potentially lead to an increased formation of toxic metabolites.


Q: Is Tafirol a common medication in other countries?

Yes, the active ingredient in Tafirol, Paracetamol (Acetaminophen), is listed on the World Health Organization's Model List of Essential Medicines. This confirms its global recognition as one of the most widely used and necessary medications for managing pain and fever.


Q: How can I tell if Tafirol is working for my symptoms?

The medication is considered to be working when you observe a reduction in pain intensity or a lowering of your body temperature (fever). Official label information recommends consulting a healthcare professional if pain or fever persists or worsens after the labeled duration of use.


Q: Is Tafirol ever used as part of a treatment plan for chronic pain?

The active ingredient is often considered a safe first-line option for managing mild to moderate pain, including certain chronic conditions like osteoarthritis. When used for an extended time period for chronic conditions, a reduced maximum daily dose is frequently recommended under medical supervision.


Q: Can Tafirol cause changes in sleep patterns?

Tafirol (acetaminophen alone) is not typically associated with causing changes in sleep patterns or sedation, and is generally not listed as a common adverse reaction in official documents. Sleepiness is more common with combination products that include sedating ingredients.


Q: Does Tafirol contain gluten or lactose?

Regulatory documents list all excipients (inactive ingredients) for the product. While the active ingredient does not contain these, certain formulations, such as specific tablets, may contain lactose or starch derivatives. The full list of excipients is detailed in the official product information.


Q: Why do some users report stomach upset with Tafirol?

Acetaminophen is generally considered to be less irritating to the stomach compared to other pain relievers. However, official adverse reaction reports do include nausea and stomach pain. Stomach upset, though uncommon, may be discussed with a healthcare professional to check for other potential causes.


Q: How quickly does Tafirol start working?

Clinical studies on the absorption rate show that the medication begins to act relatively quickly. Peak concentrations in the bloodstream are typically reached approximately 10 to 60 minutes after taking an oral dose.


Q: How long does the effect of Tafirol last?

Official dosing guidelines recommend that a single dose may be repeated every four to six hours as needed. This minimum time interval suggests that the effective duration of symptomatic relief from the medication generally falls within the four-to-six-hour period.


Q: Does Tafirol cause drowsiness or make you tired?

Drowsiness or tiredness is not listed as a common or serious adverse reaction for the single-ingredient Tafirol product in regulatory documents. This side effect is more likely to be noted if the product is a combination medicine containing sedating ingredients.


Q: Is Tafirol safe to take with blood pressure medication?

Official regulatory documents do not list common blood pressure medications (antihypertensives) as having a clinically significant interaction with Tafirol. Individuals using blood pressure medications can discuss their specific medication list with a healthcare professional to review potential interactions.


Q: What should I do if I forget to take a dose of Tafirol?

Official product information contains specific guidelines for handling a missed dose. These instructions are typically to maintain the minimum time interval between doses and to avoid taking extra medication to compensate for the missed dose.


Q: What is the recommended duration for taking Tafirol?

Product labeling specifies limits for over-the-counter use, which are typically 10 days for pain or 3 days for fever. Consulting a healthcare provider is recommended for use extending beyond these labeled periods to prevent potential long-term effects.


Q: Is Tafirol safe for people with kidney problems?

Official information includes specific warnings regarding use in people with kidney issues. Tafirol is contraindicated or requires a dose adjustment—specifically, a prolonged dosing interval—for patients with severe renal impairment.


Q: Does Tafirol affect how well birth control pills work?

There are no widely reported or clinically significant interactions noted in regulatory documents between the active ingredient in Tafirol (acetaminophen) and most oral contraceptive pills that would affect their efficacy.


Q: Is Tafirol helpful for migraine relief?

The active ingredient is widely used for acute pain, including headaches. It is also a component in some specific combination products that are approved to relieve the pain associated with migraine headache.


Q: Can Tafirol be crushed or chewed?

Unless the medication is specifically manufactured as a chewable or dispersible form, standard tablets are generally intended to be swallowed whole. Users can consult the manufacturer’s instructions regarding crushing, chewing, or splitting specific tablet types.


Q: What are the signs of an allergic reaction to Tafirol?

The appearance of allergic reaction symptoms, such as difficulty breathing, severe rash, hives, or swelling of the face, throat, or tongue, warrants immediate discontinuation and attention from a healthcare professional.


Q: Why might a pharmacist suggest Tafirol over Tylenol?

The active ingredient in both Tafirol and Tylenol is chemically the same (Paracetamol/Acetaminophen). A pharmacist might suggest one brand over the other based on factors such as local availability, a lower cost, or differences in inactive ingredients (excipients) or specific formulation (e.g., liquid concentration, tablet strength).


How should Tafirol be stored and disposed of?

How to Store and Dispose of Tafirol

Tafirol (Paracetamol/Acetaminophen) must be stored according to official labeling to maintain stability and prevent accidental ingestion.

Storage Requirements

Requirement Condition
Temperature Store at controlled room temperature (20°C to 25°C) and avoid excessive heat [Source: FDA].
Protection Must be protected from light and moisture; keep the container tightly closed in the original container [Source: EMA SmPC].
Child Safety Keep out of the sight and reach of children at all times [Source: NIH MedlinePlus].
Handling Do not freeze liquid or suspension forms [Source: NIH MedlinePlus].

Disposal

Unused or expired Tafirol should be disposed of primarily through a drug take-back program. If this is unavailable, mix the medicine with an unappealing substance, seal it in a container, and discard it in the household trash. The medication must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tafirol found in:

A-Z Index: